Company: TBPH
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001104659-25-033819
Chunk: 14

Company: Theravance Biopharma, Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 14
---
 94080. The telephone number at that location is (650) 808-6000.Our registered office is P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands. Any written requests for additional information, copies of the proxy materials and 2024 Annual Report, notices of shareholder proposals, recommendations for candidates to our board of directors, communications to our board of directors or any other communications should be sent to the U.S. subsidiary address above. IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL GENERAL MEETING TO BE HELD ON MAY 19, 2025. The proxy statement and annual report are available at http://investor.theravance.com/proxy. 8

TABLE OF CONTENTS

PROPOSAL ONE: ELECTION OF DIRECTORS General Our board of directors may establish the authorized number of directors from time to time by resolution. Our board of directors is currently comprised of nine members who are currently divided into three classes with staggered terms. Pursuant to our Amended and Restated Memorandum and Articles of Association, our board of directors will be declassified on a phased-in basis: our current Class I and Class III directors are serving for terms expiring in 2026. The Class II directors elected at the Annual Meeting will be elected for a one-year term expiring in 2026. Commencing with the election of directors at our annual general meeting in 2026 and at each annual general meeting thereafter, our board of directors will no longer be classified and all directors will be elected to serve one-year terms. A director serves in office until his or her respective successor is duly elected and qualified or until his or her earlier death, resignation or removal. Until our annual general meeting in 2026, the classification of our board of directors may have the effect of delaying or preventing changes in our control or management. Our Amended and Restated Memorandum and Articles of Association authorize only our board of directors to fill vacancies on our board of directors created by death or resignation of a director. Any director appointed by our board of directors shall hold office for the remaining term of the class of director to which he or she is appointed and shall then be eligible for re-election. Any additional directorships resulting from an increase in the authorized number of directors would be distributed among the three classes while our board of directors remains classified so that, as nearly as possible, each class would consist of one-third of the authorized